PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, United States.\', \'Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, United States.\', \'Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, Omaha, NE 68198, United States.\', \'Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78227, United States.\', \'Department of Molecular Microbiology and Immunology and Bond Life Sciences Center, University of Missouri, Columbia, MO 65212, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3748/wjg.v27.i29.4763
?:doi
?:hasPublicationType
?:journal
  • World journal of gastroenterology
is ?:pmid of
?:pmid
?:pmid
  • 34447225
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.409
?:rankingScore_hIndex
  • 123
is ?:relation_isRelatedTo_publication of
?:title
  • Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all